Sugentech Inc. Logo

Sugentech Inc.

253840.KQ

(0.0)
Stock Price

5.470,00 KRW

-11.65% ROA

-12.54% ROE

-6.37x PER

Market Cap.

89.750.351.160,00 KRW

5.89% DER

2.56% Yield

-198.95% NPM

Sugentech Inc. Stock Analysis

Sugentech Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sugentech Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Sugentech Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sugentech Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Sugentech Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sugentech Inc. Revenue
Year Revenue Growth
2015 601.109.618
2016 1.090.268.162 44.87%
2017 3.439.993.303 68.31%
2018 5.448.790.067 36.87%
2019 3.845.080.646 -41.71%
2020 41.351.848.298 90.7%
2021 77.201.041.452 46.44%
2022 101.399.255.833 23.86%
2023 8.137.732.680 -1146.04%
2023 7.132.305.545 -14.1%
2024 6.228.977.212 -14.5%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sugentech Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 419.561.130
2016 625.517.069 32.93%
2017 767.349.521 18.48%
2018 1.689.099.886 54.57%
2019 2.659.191.700 36.48%
2020 3.388.418.247 21.52%
2021 3.916.396.145 13.48%
2022 5.155.566.117 24.04%
2023 3.559.098.520 -44.86%
2023 3.620.629.267 1.7%
2024 6.110.238.184 40.74%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sugentech Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 50.518.780 100%
2019 60.812.710 16.93%
2020 218.644.650 72.19%
2021 332.580.050 34.26%
2022 675.529.540 50.77%
2023 93.969.520 -618.88%
2023 684.892.840 86.28%
2024 15.302.412.000 95.52%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sugentech Inc. EBITDA
Year EBITDA Growth
2015 -1.358.599.990
2016 -1.423.587.630 4.57%
2017 -2.641.441.690 46.11%
2018 -4.089.651.350 35.41%
2019 -6.444.345.400 36.54%
2020 23.394.586.310 127.55%
2021 36.208.627.190 35.39%
2022 28.587.457.060 -26.66%
2023 -20.676.321.840 238.26%
2023 -17.974.958.160 -15.03%
2024 -16.226.346.400 -10.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sugentech Inc. Gross Profit
Year Gross Profit Growth
2015 -72.941.054
2016 148.366.735 149.16%
2017 1.187.322.996 87.5%
2018 2.454.567.454 51.63%
2019 -285.986.679 958.28%
2020 31.115.641.857 100.92%
2021 47.509.855.784 34.51%
2022 42.659.778.484 -11.37%
2023 -9.090.437.400 569.28%
2023 -5.880.868.099 -54.58%
2024 -5.729.305.160 -2.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sugentech Inc. Net Profit
Year Net Profit Growth
2015 -1.511.996.258
2016 -1.558.392.021 2.98%
2017 -20.960.485.413 92.57%
2018 -40.915.428.995 48.77%
2019 -9.561.056.493 -327.94%
2020 -41.018.413.359 76.69%
2021 36.151.559.440 213.46%
2022 26.716.630.860 -35.31%
2023 -2.380.147.680 1222.48%
2023 -17.238.284.503 86.19%
2024 7.077.444.000 343.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sugentech Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 -187
2016 -193 2.6%
2017 -2.292 91.62%
2018 -5.807 60.52%
2019 -774 -651.1%
2020 -2.935 73.65%
2021 2.352 224.74%
2022 1.686 -39.58%
2023 -353 578.69%
2023 -1.090 67.71%
2024 463 335.42%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sugentech Inc. Free Cashflow
Year Free Cashflow Growth
2015 -2.556.622.568
2016 -1.472.276.432 -73.65%
2017 -1.312.643.433 -12.16%
2018 -4.999.490.329 73.74%
2019 -5.979.800.948 16.39%
2020 9.895.112.881 160.43%
2021 33.422.752.831 70.39%
2022 14.023.632.856 -138.33%
2023 -5.392.382.560 360.06%
2023 -17.938.648.986 69.94%
2024 -2.576.568.031 -596.22%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sugentech Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 -1.197.283.537
2016 -1.335.399.006 10.34%
2017 -909.594.013 -46.81%
2018 -3.134.053.492 70.98%
2019 -4.011.329.346 21.87%
2020 14.332.738.086 127.99%
2021 38.955.129.427 63.21%
2022 30.427.994.726 -28.02%
2023 -2.560.305.340 1288.45%
2023 -12.153.244.989 78.93%
2024 -2.186.687.440 -455.78%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sugentech Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 1.359.339.031
2016 136.877.426 -893.11%
2017 403.049.420 66.04%
2018 1.865.436.837 78.39%
2019 1.968.471.602 5.23%
2020 4.437.625.205 55.64%
2021 5.532.376.596 19.79%
2022 16.404.361.870 66.27%
2023 2.832.077.220 -479.23%
2023 5.785.403.997 51.05%
2024 389.880.591 -1383.89%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sugentech Inc. Equity
Year Equity Growth
2015 5.398.492.537
2016 8.588.475.125 37.14%
2017 -32.810.729.400 126.18%
2018 15.456.352.623 312.28%
2019 24.319.877.519 36.45%
2020 63.143.337.735 61.48%
2021 100.745.048.408 37.32%
2022 140.576.943.704 28.33%
2023 112.454.854.893 -25.01%
2023 130.776.416.110 14.01%
2024 110.265.162.278 -18.6%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sugentech Inc. Assets
Year Assets Growth
2015 6.947.475.156
2016 9.965.913.059 30.29%
2017 18.277.197.841 45.47%
2018 24.371.975.092 25.01%
2019 45.420.145.638 46.34%
2020 72.455.407.141 37.31%
2021 155.562.671.699 53.42%
2022 173.296.797.588 10.23%
2023 133.187.019.360 -30.12%
2023 155.866.412.000 14.55%
2024 120.896.354.729 -28.93%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sugentech Inc. Liabilities
Year Liabilities Growth
2015 1.519.482.619
2016 1.377.437.933 -10.31%
2017 51.087.927.242 97.3%
2018 8.915.622.469 -473.02%
2019 21.100.268.119 57.75%
2020 9.312.069.406 -126.59%
2021 54.817.623.291 83.01%
2022 32.719.853.884 -67.54%
2023 20.732.164.467 -57.82%
2023 25.089.995.890 17.37%
2024 10.631.192.451 -136%

Sugentech Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
463.45
Net Income per Share
-922.04
Price to Earning Ratio
-6.37x
Price To Sales Ratio
12.68x
POCF Ratio
-5.42
PFCF Ratio
-5.05
Price to Book Ratio
0.81
EV to Sales
11.09
EV Over EBITDA
-5.16
EV to Operating CashFlow
-4.75
EV to FreeCashFlow
-4.41
Earnings Yield
-0.16
FreeCashFlow Yield
-0.2
Market Cap
89,75 Bil.
Enterprise Value
78,48 Bil.
Graham Number
12245.62
Graham NetNet
3487.32

Income Statement Metrics

Net Income per Share
-922.04
Income Quality
1.17
ROE
-0.13
Return On Assets
-0.12
Return On Capital Employed
-0.18
Net Income per EBT
0.72
EBT Per Ebit
0.97
Ebit per Revenue
-2.84
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
1.22
Research & Developement to Revenue
0.59
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
-0.47
Operating Profit Margin
-2.84
Pretax Profit Margin
-2.76
Net Profit Margin
-1.99

Dividends

Dividend Yield
0.03
Dividend Yield %
2.56
Payout Ratio
0
Dividend Per Share
150

Operating Metrics

Operating Cashflow per Share
-1082.11
Free CashFlow per Share
-1164.65
Capex to Operating CashFlow
-0.08
Capex to Revenue
0.18
Capex to Depreciation
0.26
Return on Invested Capital
-0.13
Return on Tangible Assets
-0.12
Days Sales Outstanding
430.72
Days Payables Outstanding
13.89
Days of Inventory on Hand
225.27
Receivables Turnover
0.85
Payables Turnover
26.29
Inventory Turnover
1.62
Capex per Share
82.54

Balance Sheet

Cash per Share
3.563,61
Book Value per Share
7.220,05
Tangible Book Value per Share
7220.05
Shareholders Equity per Share
7228.21
Interest Debt per Share
504.63
Debt to Equity
0.06
Debt to Assets
0.05
Net Debt to EBITDA
0.74
Current Ratio
8.63
Tangible Asset Value
110,27 Bil.
Net Current Asset Value
60,76 Bil.
Invested Capital
98549269309
Working Capital
63,12 Bil.
Intangibles to Total Assets
0
Average Receivables
6,05 Bil.
Average Payables
0,29 Bil.
Average Inventory
6391899494
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sugentech Inc. Dividends
Year Dividends Growth
2022 150
2023 150 0%

Sugentech Inc. Profile

About Sugentech Inc.

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test items; and self-testing products, including digital ovulation, pregnancy test, and early sign pregnancy test, as well as mobile testing products. It also provides point of care testing analyzers and test items for testing of M.tuberculosis, M.bovis, SARS-CoV-2 antibodies and antigens, flu A/B antigens, and CRP/hsCRP /dualCRP, as well as for measuring procalcitonin, troponin I, hemoglobinA1c, human chorionic gonadotropin, immunoglobulin E, and influenza A/B. The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.

CEO
Jin Mi
Employee
138
Address
187, Techno 2-ro
Daejeon, 34028

Sugentech Inc. Executives & BODs

Sugentech Inc. Executives & BODs
# Name Age
1 Jin Mi
Chief Executive Officer
70

Sugentech Inc. Competitors

Seegene, Inc. Logo
Seegene, Inc.

096530.KQ

(0.0)
LabGenomics Co., Ltd. Logo
LabGenomics Co., Ltd.

084650.KQ

()
Humasis Co. Ltd. Logo
Humasis Co. Ltd.

205470.KQ

(0.0)
Pharmicell Co., Ltd. Logo
Pharmicell Co., Ltd.

005690.KS

(1.8)